RDY
Dr. Reddy's Laboratories Ltd.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IN
$12.19
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- 26.01x
- P/E 2026E
- 27.51x
- P/E 2027E
- 20.78x
- P/E 2028E
- 16.98x
- P/S forward
- 2.84x
Trailing multiples
Trailing twelve months
- P/E TTM
- 29.34x
- PEG TTM
- 2.29x
- Price / book
- 2.54x
- Price / sales
- 2.92x
- Price / cash flow
- 23.75x
Enterprise value
- Enterprise value
- $10.1B
- EV / sales
- 2.91x
- EV / EBITDA
- 17.40x
- EV / EBIT
- 27.48x
- Market cap
- $10.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026